Chi's presentation focused on first -
line treatment outcomes and correlations with deep targeted sequencing of circulating tumor (ctDNA) that occurred at baseline.
Not exact matches
An important trigger this year will be the
outcome of a study where Darzalex is being tested as first -
line treatment in combination with Celgene Corp's Revlimid.
He added «The point - of - entry
treatment systems that we have already voluntarily installed, and our funding of the planned water
line extensions, show our commitment to achieving this
outcome.»
While clomiphene is a first -
line treatment used to induce ovulation in women with PCOS, it has downsides — namely that in a significant number of women it does not lead to improved ovulation or live births, and if it does induce ovulation, it frequently results in pregnancies with multiples who face much higher negative
outcomes including death.
«The TAILOR study draws out attention to the fact that
outcomes are poor in second -
line treatment of non — small - cell lung cancer, with our available
treatments resulting in median progression - free survivals of two or three months,» said Benjamin Solomon, MBBS, PhD, of Peter MacCallum Cancer Centre in Melbourne.
Acute myeloid leukemia (AML) is the leading cause of leukemia mortality in the United States.1 Curative
treatment involves intensive induction chemotherapy, before proceeding to either consolidation chemotherapy or allogeneic stem cell transplantation based on the patient's risk for relapse.2 This approach has been employed for > 4 decades and, although most individuals achieve complete remissions with front -
line therapy, 3 the majority of patients ultimately relapse with drug - resistant disease, and overall survival rates remain disappointingly poor.4 The limited ability of many patients to tolerate the intense chemotherapy - based
treatments, in particular hematological toxicity, further contributes to the poor
outcomes noted in this disease.
By providing comprehensive support through our product
line, clinical education, and practice development programs, we maximize the potential for successful patient
treatment outcomes.
The Canadian study that isolated avocado's compound avocotin B to observe its effect on AML cells» conversion to apoptosis mode started with this
line: «
Treatment regimens for acute myeloid leukemia (AML) continue to offer weak clinical
outcomes.»
Significant differences in the
outcome variables were found for the in - person
treatment group and for the on -
line only versions of the program, versus a wait - listed control group.